Skip to main content

Table 3 Means and prevalence of 25(OH)D categories based on original and standardized 25(OH)D levels of GNHIES98a

From: Implications of standardization of serum 25-hydroxyvitamin D data for the evaluation of vitamin D status in Germany, including a temporal analysis

 

Mean serum 25(OH)D levels

Serum 25(OH)D levels by thresholds of the IOM 2011 in %

< 30 nmol/l

30- < 50 nmol/l

> = 50 nmol/l

Original

Standardized

Original

Standardized

Original

Standardized

Original

Standardized

nmol/l (95% CI)

nmol/l (95% CI)

% (95% CI)

% (95% CI)

% (95% CI)

% (95% CI)

% (95% CI)

% (95% CI)

Women

55.4 (51.8–59.0)

62.0 (58.9–65.1)

23.8 (20.2–27.8)

15.8 (12.8–19.3)

34.0 (30.8–37.3)

28.0 (25.2–30.9)

42.2 (38.3–46.2)

56.3 (52.3–60.2)

 18–29 years

65.4 (59.5–71.4)

70.8 (65.7–75.8)

19.5 (14.4–25.9)

18.7 (12.9–26.2)

26.5 (21.8–31.8)

23.7 (18.9–29.3)

54.0 (47.3–60.5)

57.6 (50.3–64.6)

 30–39 years

60.3 (55.4–65.2)

66.6 (62.7–70.5)

19.0 (15.2–23.4)

14.4 (10.6–19.4)

32.4 (28.1–37.0)

26.6 (22.2–31.6)

48.6 (47.3–53.7)

58.9 (52.3–65.3)

 40–49 years

57.5 (52.8–62.3)

64.4 (60.4–68.4)

21.2 (16.6–26.7)

14.9 (10.5–20.7)

32.5 (27.3–38.2)

30.5 (24.8–36.9)

46.3 (40.5–52.1)

54.6 (46.6–62.4)

 50–59 years

52.9 (47.4–58.4)

60.2 (55.4–65.1)

24.2 (18.8–30.5)

17.8 (13.3–23.4)

36.1 (30.5–42.1)

27.4 (22.1–33.4)

39.7 (33.5–46.2)

54.8 (47.5–61.9)

 60–69 years

49.3 (44.4–54.2)

56.5 (52.0–61.1)

26.7 (20.1–34.5)

7.3 (4.4–11.8)

40.9 (34.1–48.2)

23.9 (18.3–30.6)

32.4 (26.0–39.5)

68.8 (61.3–75.4)

 70–79 years

40.9 (35.0–46.9)

48.2 (42.3–54.1)

37.4 (27.4–48.7)

18.5 (10.7–29.9)

37.7 (28.2–48.3)

31.7 (21.4–44.1)

24.9 (16.3–36.0)

49.9 (37.5–62.3)

Men

53.4 (49.1–57.6)

60.9 (57.1–64.7)

23.6 (19.8–28.0)

15.1 (12.2–18.7)

33.2 (29.9–36.5)

26.9 (23.7–30.5)

43.2 (38.1–48.5)

57.9 (52.7–62.9)

 18–29 years

52.2 (47.5–56.8)

60.1 (55.5–64.7)

23.3 (16.9–31.1)

11.9 (8.4–16.7)

31.4 (25.6–37.9)

19.8 (15.5–25.0)

45.3 (38.0–52.8)

68.3 (61.5–74.4)

 30–39 years

55.2 (50.0–60.3)

62.3 (57.8–66.9)

22.9 (17.8–28.9)

11.7 (8.7–15.6)

33.4 (28.9–38.3)

27.3 (24.0–31.0)

43.7 (37.8–49.8)

60.9 (56.3–65.4)

 40–49 years

51.5 (44.9–58.1)

59.2 (53.2–65.3)

25.4 (19.3–32.5)

13.1 (9.5–17.9)

34.4 (28.0–41.5)

27.7 (23.5–32.3)

40.2 (32.0–49.1)

59.2 (53.8–64.4)

 50–59 years

49.4 (44.4–54.4)

57.1 (52.4–61.9)

26.8 (21.4–33.1)

16.0 (11.7–21.4)

34.7 (29.0–40.9)

28.2 (22.7–34.4)

38.5 (31.3–46.2)

55.8 (48.9–62.2)

 60–69 years

60.3 (54.2–66.5)

67.7 (62.5–72.8)

15.3 (10.7–21.4)

16.9 (11.7–23.8)

33.9 (27.5–40.9)

33.8 (27.9–40.4)

50.8 (42.9–58.7)

49.2 (42.3–56.1)

 70–79 years

51.1 (43.3–58.9)

58.4 (50.8–66.0)

31.3 (21.0–44.0)

30.2 (20.3–42.3)

28.2 (18.3–40.8)

33.0 (24.0–43.5)

40.4 (29.2–52.8)

36.9 (27.0–47.9)

Total

54.4 (50.8–58.0)

61.5 (58.3–64.7)

23.7 (20.3–27.5)

15.5 (12.8–18.6)

33.6 (31.0–36.3)

27.5 (25.1–30.0)

42.7 (38.7–46.8)

57.1 (53.0–61.1)

  1. 25(OH)D Serum 25-hydroxyvitamin D, GNHIES98 German National Health Interview and Examination Survey 1998, IOM Institute of Medicine, USA, CI confidence interval
  2. a Results are weighted population estimates